Results of a clinical phase I dose-escalation study of cytarabinein combination with fixed-dose vinorelbine, paclitaxel, etoposideand cisplatin for the treatment of relapsed/refractory lymphoma-Reference-Cited by-同舟云学术

Results of a clinical phase I dose-escalation study of cytarabinein combination with fixed-dose vinorelbine, paclitaxel, etoposideand cisplatin for the treatment of relapsed/refractory lymphoma

Published:2006-01 Issue:10 Volume:47 Page:2155-2162
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Lonial Sagar,Arellano Martha,Hutcherson Donald,Langston Amelia,Flowers Christopher,Heffner L. T.,Winton Elliott,Jo Lechowicz Mary,Waller Edmund K.

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.1080/10428190600774923

Reference29 articles.

1. Advanced Hodgkin’s Disease: ABVD Is Better, Yet Is Not Good Enough!

2. Ifosfamide, Carboplatin, and Etoposide: A Highly Effective Cytoreduction and Peripheral-Blood Progenitor-Cell Mobilization Regimen for Transplant-Eligible Patients With Non-Hodgkin's Lymphoma

3. Treatment of non-Hodgkin lymphoma

4. Ifosfamide, carboplatin, etoposide (ICE)-based second-line chemotherapy for the management of relapsed and refractory aggressive non-Hodgkin’s lymphoma

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An overview on anti-tubulin agents for the treatment of lymphoma patients;Pharmacology & Therapeutics;2020-07

2. Non-Hodgkin Lymphoma in Adults;The American Cancer Society's Oncology in Practice;2018-02-16

3. Advancement in high dose therapy and autologous stem cell rescue in lymphoma;WORLD J STEM CELLS;2015

4. Vinorelbine, Paclitaxel, Etoposide, Cisplatin, and Cytarabine (VTEPA) Is an Effective Second Salvage Therapy for Relapsed/Refractory Hodgkin Lymphoma;Clinical Lymphoma Myeloma and Leukemia;2013-12

5. Rituximab-hyperfractionated cyclophosphamide, vincristine, adriamycin and dexamethasone alternating with high-dose cytarabine and methotrexate for aggressive non-Hodgkin lymphoma;Leukemia & Lymphoma;2012-04